Table 1 Correlations between expression levels of MCM3AP-AS1 and patients’ clinical data
Items | Groups | Cases | High-expression | Low-expression | χ2 | p value |
|---|---|---|---|---|---|---|
Age | ≥ 50 | 32 | 14 | 18 | 1.07 | 0.3 |
< 50 | 28 | 16 | 12 | |||
AJCC | I | 11 | 5 | 6 | 1.93 | 0.59 |
II | 18 | 10 | 8 | |||
III | 20 | 8 | 12 | |||
IV | 11 | 7 | 4 | |||
Grade | 1 | 17 | 9 | 8 | 0.1 | 0.95 |
2 | 23 | 11 | 12 | |||
3 | 20 | 10 | 10 | |||
BMI | ≥ 24 | 26 | 12 | 14 | 0.27 | 0.6 |
< 24 | 34 | 18 | 16 | |||
Smoking | Yes | 18 | 7 | 11 | 1.27 | 0.26 |
No | 42 | 23 | 19 | |||
Pathology classification | Well+Mod | 40 | 21 | 19 | 0.3 | 0.58 |
Poor | 20 | 9 | 11 | |||
Grade | G1 | 24 | 14 | 10 | 1.11 | 0.29 |
G2/3 | 36 | 16 | 20 | |||
Endocervical invasion | Yes | 44 | 23 | 21 | 0.34 | 0.56 |
No | 16 | 7 | 9 | |||
Ovarian involvement | Yes | 22 | 13 | 9 | 1.15 | 0.28 |
No | 38 | 17 | 21 | |||
Parametrium involvement | Yes | 18 | 11 | 7 | 1.27 | 0.26 |
No | 42 | 19 | 23 | |||
Lymph nodes metastasis | Yes | 15 | 7 | 8 | 0.09 | 0.77 |
No | 45 | 23 | 22 |